Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Tg Therapeuticscmn (TGTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 394,604
  • Shares Outstanding, K 82,897
  • Annual Sales, $ 150 K
  • Annual Income, $ -118,480 K
  • 36-Month Beta 2.07
  • Price/Sales 2,263.31
  • Price/Cash Flow N/A
  • Price/Book 5.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.45
  • Number of Estimates 4
  • High Estimate -0.41
  • Low Estimate -0.49
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +2.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.87 +23.00%
on 02/05/19
5.00 -4.80%
on 01/22/19
+0.14 (+3.03%)
since 01/15/19
3-Month
3.32 +43.37%
on 12/24/18
5.59 -14.92%
on 11/16/18
-0.61 (-11.36%)
since 11/15/18
52-Week
3.32 +43.37%
on 12/24/18
17.35 -72.56%
on 03/09/18
-7.89 (-62.37%)
since 02/15/18

Most Recent Stories

More News
HMS Holdings (HMSY) to Report Q4 Earnings: What's in Store?

HMS Holdings (HMSY) expects to gain from its total population management or TPM business in fourth-quarter 2018.

MGNX : 21.84 (+3.41%)
TGTX : 4.76 (+1.28%)
MASI : 129.62 (+0.63%)
HMSY : 32.21 (+3.01%)
Key Factors Likely to Shape CVS Health's (CVS) Q4 Earnings

CVS Health (CVS) expects drug price inflation, product launches and higher utilization to fuel growth in Q4.

TGTX : 4.76 (+1.28%)
MGNX : 21.84 (+3.41%)
CVS : 69.53 (+2.72%)
BDSI : 4.63 (+3.12%)
Look for Shares of Tg Therapeutics to Potentially Pullback after Yesterday's 4.74% Rise

Tg Therapeutics (NASDAQ:TGTX) traded in a range yesterday that spanned from a low of $4.22 to a high of $4.42. Yesterday, the shares gained 4.7%, which took the trading range above the 3-day high of...

TGTX : 4.76 (+1.28%)
Can M&A Activity Drive Quest Diagnostics (DGX) Q4 Earnings?

Quest Diagnostics' (DGX) increasing partnerships with other health care leaders and strategic acquisitions are promising abundant opportunities for the company's top and bottom-line improvement.

MGNX : 21.84 (+3.41%)
TGTX : 4.76 (+1.28%)
DGX : 87.81 (+2.70%)
BDSI : 4.63 (+3.12%)
TG Therapeutics (TGTX) Upgraded to Buy: Here's What You Should Know

TG Therapeutics (TGTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

TGTX : 4.76 (+1.28%)
Has TG Therapeutics (TGTX) Outpaced Other Medical Stocks This Year?

Is (TGTX) Outperforming Other Medical Stocks This Year?

TGTX : 4.76 (+1.28%)
Tg Therapeutics Falls 3.21% on Heavy Volume: Watch For Potential Rebound

Tg Therapeutics (NASDAQ:TGTX) traded in a range yesterday that spanned from a low of $4.22 to a high of $4.44. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $4.29...

TGTX : 4.76 (+1.28%)
TG Therapeutics Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Umbralisib for the Treatment of Marginal Zone Lymphoma

TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company dedicated to developing medicines for patients with B-cell mediated diseases, today announced that the U.S. Food and Drug Administration...

TGTX : 4.76 (+1.28%)
Canopy Growth (CGC) in Focus: Stock Moves 11.1% Higher

Canopy Growth (CGC) shares rose more than 11% in the last trading session, amid huge volumes.

TGTX : 4.76 (+1.28%)
CGC : 47.56 (+3.12%)
Watch for Tg Therapeutics to Potentially Rebound After Falling 4.26% Yesterday

Tg Therapeutics (NASDAQ:TGTX) traded in a range yesterday that spanned from a low of $4.72 to a high of $4.72. Yesterday, the shares fell 4.3%, which took the trading range below the 3-day low of $4.75...

TGTX : 4.76 (+1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade TGTX with:

Business Summary

TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various...

See More

Key Turning Points

2nd Resistance Point 4.90
1st Resistance Point 4.83
Last Price 4.76
1st Support Level 4.68
2nd Support Level 4.59

See More

52-Week High 17.35
Fibonacci 61.8% 11.99
Fibonacci 50% 10.34
Fibonacci 38.2% 8.68
Last Price 4.76
52-Week Low 3.32

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar